Literature DB >> 27865873

Signaling via G proteins mediates tumorigenic effects of GPR87.

Kristine Niss Arfelt1, Suzan Fares1, Alexander H Sparre-Ulrich1, Gertrud M Hjortø1, Lærke S Gasbjerg1, Ann-Sofie Mølleskov-Jensen1, Tau Benned-Jensen1, Mette M Rosenkilde2.   

Abstract

G protein-coupled receptors (GPCRs) constitute a large protein family of seven transmembrane (7TM) spanning proteins that regulate multiple physiological functions. GPR87 is overexpressed in several cancers and plays a role in tumor cell survival. Here, the basal activity of GPR87 was investigated in transiently transfected HEK293 cells, revealing ligand-independent coupling to Gαi, Gαq and Gα12/13. Furthermore, GPR87 showed a ligand-independent G protein-dependent activation of the downstream transcription factors CREB, NFκB, NFAT and SRE. In tetracycline-induced Flp-In T-Rex-293 cells, GPR87 induced cell clustering presumably through Gα12/13 coupling. In a foci formation assay using retrovirally transduced NIH3T3 cells, GPR87 showed a strong in vitro transforming potential, which correlated to the in vivo tumor induction in nude mice. Importantly, we demonstrate that the transforming potential of GPR87 was correlated to the receptor signaling, as the signaling-impaired mutant R139A (Arg in the conserved "DRY"-motif at the bottom of transmembrane helix 3 of GPR87 substituted to Ala) showed a lower in vitro cell transformation potential. Furthermore, R139A lost the ability to induce cell clustering. In summary, we show that GPR87 is active through several signaling pathways and that the signaling activity is linked to the receptor-induced cell transformation and clustering. The robust surface expression of GPR87 and general high druggability of GPCRs make GPR87 an attractive future anticancer target for drugs that - through inhibition of the receptor signaling - will inhibit its transforming properties.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anticancer drugs; Cell clustering; Cell signaling,; Cell transformation; GPR87

Mesh:

Substances:

Year:  2016        PMID: 27865873     DOI: 10.1016/j.cellsig.2016.11.009

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  9 in total

1.  Overexpression of G protein-coupled receptor GPR87 promotes pancreatic cancer aggressiveness and activates NF-κB signaling pathway.

Authors:  Li Wang; Wei Zhou; Yunfeng Zhong; Yongbao Huo; Ping Fan; Sudong Zhan; Jun Xiao; Xin Jin; Shanmiao Gou; Tao Yin; Heshui Wu; Tao Liu
Journal:  Mol Cancer       Date:  2017-03-14       Impact factor: 27.401

2.  Versatile approach for functional analysis of human proteins and efficient stable cell line generation using FLP-mediated recombination system.

Authors:  Roman J Szczesny; Katarzyna Kowalska; Kamila Klosowska-Kosicka; Aleksander Chlebowski; Ewelina P Owczarek; Zbigniew Warkocki; Tomasz M Kulinski; Dorota Adamska; Kamila Affek; Agata Jedroszkowiak; Anna V Kotrys; Rafal Tomecki; Pawel S Krawczyk; Lukasz S Borowski; Andrzej Dziembowski
Journal:  PLoS One       Date:  2018-03-28       Impact factor: 3.240

3.  A double-Flp-in method for stable overexpression of two genes.

Authors:  Ole Jensen; Salim Ansari; Lukas Gebauer; Simon F Müller; Kira A A T Lowjaga; Joachim Geyer; Mladen V Tzvetkov; Jürgen Brockmöller
Journal:  Sci Rep       Date:  2020-08-20       Impact factor: 4.379

4.  Gonadal Cycle-Dependent Expression of Genes Encoding Peptide-, Growth Factor-, and Orphan G-Protein-Coupled Receptors in Gonadotropin- Releasing Hormone Neurons of Mice.

Authors:  Csaba Vastagh; Veronika Csillag; Norbert Solymosi; Imre Farkas; Zsolt Liposits
Journal:  Front Mol Neurosci       Date:  2021-01-18       Impact factor: 5.639

5.  Vitamin E and Lactobacillus Provide Protective Effects Against Liver Injury Induced by HgCl2: Role of CHOP, GPR87, and mTOR Proteins.

Authors:  Ahlam Alhusaini; Shahad Alghilani; Waad Alhuqbani; Iman H Hasan
Journal:  Dose Response       Date:  2021-04-26       Impact factor: 2.658

6.  GPR87 Promotes Metastasis through the AKT-eNOS-NO Axis in Lung Adenocarcinoma.

Authors:  Hye-Mi Ahn; Eun-Young Choi; Youn-Jae Kim
Journal:  Cancers (Basel)       Date:  2021-12-21       Impact factor: 6.639

7.  A Novel Risk Factor Model Based on Glycolysis-Associated Genes for Predicting the Prognosis of Patients With Prostate Cancer.

Authors:  Kaixuan Guo; Cong Lai; Juanyi Shi; Zhuang Tang; Cheng Liu; Kuiqing Li; Kewei Xu
Journal:  Front Oncol       Date:  2021-09-14       Impact factor: 6.244

8.  Distinct Roles of Extracellular Domains in the Epstein-Barr Virus-Encoded BILF1 Receptor for Signaling and Major Histocompatibility Complex Class I Downregulation.

Authors:  Suzan Fares; Katja Spiess; Emma T B Olesen; Jianmin Zuo; Sarah Jackson; Thomas N Kledal; Mark R Wills; Mette M Rosenkilde
Journal:  mBio       Date:  2019-01-15       Impact factor: 7.867

9.  GPR27 Regulates Hepatocellular Carcinoma Progression via MAPK/ERK Pathway.

Authors:  Hongxv Wang; Danyu Du; Jianwen Huang; Shuai Wang; Xv He; Shengtao Yuan; Jing Xiao
Journal:  Cancer Manag Res       Date:  2022-03-17       Impact factor: 3.989

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.